Skip to content

Author

Adriano Fabi

We have 4 of 30 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Short- and Long-term Patency of Prophylactic and Therapeutic Lymphovenous Anastomosis for Extremity Lymphedema: A Systematic Review

Background: The clinical effectiveness of lymphovenous anastomosis (LVA) for extremity lymphedema often decreases after 6–12 months. This waning effect is believed to be associated with loss of anastomotic patency, but patency rates remain poorly defined in the current literature. Consequently, the goal of this systema...

Adriano Fabi, Séverin R. Wendelspiess, C. Appenzeller-Herzog et al. · 0 citations
Open access Sep 2026

Intramedullary Femoral Nailing—Blade Versus Screw: A Risk Analysis of Implant-Related Complications in Trochanteric Femoral Fractures

Background/Objectives: Previous studies comparing helical blade and lag screw fixation have often compared different cephalomedullary nail systems, leaving the specific association of the cephalic fixation element with clinical outcomes unclear. This study compared implant-related complications after fixation with the...

Theodoros Loupasis, Method Kabelitz, Nikolaos Trygonis et al. · 0 citations
Review Open access Sep 2026

Artificial Intelligence and Robotic Surgery in Lymphedema: A Scoping Review of Current Applications, Clinical Translation, and Evidence Gaps

The integration of AI-assisted systems into the surgical management of chronic lymphedema has the potential to reduce diagnostic delays and to enable early therapeutic intervention, but translation to routine practice will require multicenter validation, transparent reporting, and demonstration of clinical utility, cos...

Adriano Fabi, S. Wendelspiess, Felix J. Klimitz et al. · 2 citations
Open access Jul 2026

AI-enabled clinical decision support in breast cancer care: a blinded multicenter benchmarking study comparing medically specialized with a general-purpose system

The results indicate that while regulatory clearance and domain specialization address key requirements for AI-enabled clinical decision support systems, these factors alone do not translate into superior performance in breast cancer care.

Jonas Freudenberg, J. Knitza, N. Gremke et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.